Related references
Note: Only part of the references are listed.Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2020)
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting
Maarten van der Kroef et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
Paola Di Benedetto et al.
SCIENTIFIC REPORTS (2019)
The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis
Barbara Mariotti et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation
Tuong N. Vu et al.
RESPIRATORY RESEARCH (2019)
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
Aida Moreno-Moral et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Effect of glucocorticoids on miRNA expression spectrum of rat femoral head microcirculation endothelial cells
Ju'an Yue et al.
GENE (2018)
Targeting interferons as a strategy for systemic sclerosis treatment
Marzena Ciechomska et al.
IMMUNOLOGY LETTERS (2018)
Phenotypic and Transcriptomic analysis of Peripheral Blood Plasmacytoid and conventional Dendritic cells in early Drug naive rheumatoid arthritis
Faye A. H. Cooles et al.
FRONTIERS IN IMMUNOLOGY (2018)
New insights into the genetics and epigenetics of systemic sclerosis
Chiara Angiolilli et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
The role of microRNA-5196 in the pathogenesis of systemic sclerosis
Marzena Ciechomska et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis
Ramazan Rezaei et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
Marzia Rossato et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The Role of Interferons in Inflammation and Inflammasome Activation
Natasa Kopitar-Jerala
FRONTIERS IN IMMUNOLOGY (2017)
Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes
Antonella Farina et al.
ARTHRITIS RESEARCH & THERAPY (2017)
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Human Monocytes Engage an Alternative Inflammasome Pathway
Moritz M. Gaidt et al.
IMMUNITY (2016)
Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease
Tracy A. Delaney et al.
JOURNAL OF IMMUNOLOGY (2016)
Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases
Marzena Ciechomska et al.
MEDIATORS OF INFLAMMATION (2016)
IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
Steven O'Reilly et al.
SCIENTIFIC REPORTS (2016)
Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-2
Marzena Ciechomska et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis
Xiang Guo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis
Marzena Ciechomska et al.
PLOS ONE (2014)
MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats
Congshan Jiang et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
Marzena Ciechomska et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells
Julien Pothlichet et al.
PLOS PATHOGENS (2013)
MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha
Yingke Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
The role of miR-26 in tumors and normal tissues (Review)
Jie Gao et al.
ONCOLOGY LETTERS (2011)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
MicroRNA Regulation of IFN-β Protein Expression: Rapid and Sensitive Modulation of the Innate Immune Response
Kenneth W. Witwer et al.
JOURNAL OF IMMUNOLOGY (2010)
MicroRNAs: Small RNAs With Big Effects
Dany Anglicheau et al.
TRANSPLANTATION (2010)
Interferon β for rheumatoid arthritis: new clothes for an old kid on the block
Margriet J. Vervoordeldonk et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Human monocytes represent a competitive source of interferon-α in peripheral blood
Leo Hansmann et al.
CLINICAL IMMUNOLOGY (2008)
Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats
J. Adriaansen et al.
JOURNAL OF GENERAL VIROLOGY (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2004)
Share Paper
